Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.11.12.766215

The activation-deactivation cycle of human PIEZO1

Abstract

PIEZO1 is a cation channel that is primarily activated through mechanical force, and activation has been shown to be influenced by membrane curvature. PIEZO1 is ubiquitously expressed and plays critical roles in various patho-/physiological processes such as inflammatory diseases or red blood cell volume regulation. Here we combine coarse-grained and atomistic simulations in which human PIEZO1 is embedded in a curved membrane and subjected to simulations under controlled membrane tension and a physiological transmembrane potential, allowing the gating cycle to be reconstructed at atomic resolution. Systematic pressure adaptation identifies an activation regime in which the channel flattens progressively, and ion permeation quantitatively reproduces the experimental conductance of 36 pS. Furthermore, the R2456-E2117 salt bridge couples pore lipid retention to the anchor domain and disrupting it reproduces the phenotypes of the disease-associated R2456H and R2456C variants. PIEZO activation is transmitted through an interconnected network of contact rearrangements that ultimately reshapes the yoda1 binding pocket at the THU8/THU9 interface. This state-dependent remodelling rationalises the pharmacology of yoda1 and offers a framework for the structure-based design of PIEZO1 modulators.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Massa, J., Frieg, B., Tyrchan, C., Koch, O.. 2026-11-16. The activation-deactivation cycle of human PIEZO1. https://doi.org/10.64898/2026.11.12.766215

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Distinct changes in brain and peripheral oxygen levels induced by synthetic opioids of the nitazene family

Nitazenes are a category of synthetic opioids, some of which have high analgesic potential but also high toxicity, which has historically prevented their development as therapeutic drugs. Like fentanyl, nitazenes induce respiratory depression, a primary factor in their toxicity. Recently, a nitazene derivative called N-desethyl-fluornitrazene (DFNZ) was shown to have high analgesic properties with weak hypoxic effects. To better characterize the hypoxic effects of DFNZ relative to its parent, fluornitrazene (FNZ) and the prototypical nitazene etonitazene, we used amperometric oxygen sensors in freely moving rats to examine oxygen dynamics in the nucleus accumbens (NAc) and the subcutaneous space, using fentanyl as a comparison. All drugs induced similar patterns of subcutaneous hypoxia, with rapid dose-dependent oxygen decreases. In the NAc, all opioids, except DFNZ, at low iv doses (1-5 g/kg) induced moderate but significant brain oxygen increases. At higher doses (>10 g/kg), oxygen levels for all opioids, except DFNZ, showed a biphasic response; robust hypoxia followed by a weaker rebound-like hyperoxia. Etonitazene at 30 g/kg had the largest and most prolonged brain hypoxia compared to the other drugs, without the rebound-like hyperoxia. These findings indicate that etonitazene and FNZ mimic the effects of fentanyl, inducing dose-dependent brain and peripheral hypoxia. In contrast, DFNZ induces very weak hypoxia seen minimally at very high iv doses (300-1000 g/kg). Our findings substantiate the low hypoxic potency of DFNZ and indicate that not all nitazenes are characterized by high potential for toxicity. As such, the development of nitazenes as analgesics should not be categorically dismissed.

pharmacology and toxicology↗

The key role of oxidation state and flake size in the ecotoxicological impact of industrial graphene oxide nanoflakes

Graphene oxide (GO) is a widely used nanomaterial across various scientific and technological fields. Environmental exposure to GO and consequent ecotoxicological effects have been largely reported. Despite the significant efforts and illuminating conclusions, establishing fair pairwise correlations between material and toxicity descriptors remains challenging and controversial. Key drawbacks in GO ecotoxicological studies to date include a lack of standardized materials, poorly defined descriptors, and insufficient material variants. Here, we establish the first comprehensive framework to tackle the multidimensional ecotoxicology of GO. We perform thorough material characterization to derive descriptors that precisely define four key GO variants used in industrial scale-up, with differing flake granularity and oxidation extent. These GO variants are evaluated against toxicological endpoint descriptors across two animal models (Daphnia magna and Caenorhabditis elegans) and two plant models (rice and pepper). Our findings underscore the inherently multidimensional nature of GO toxicity by identifying key physicochemical properties associated with it. This study provides an unprecedented platform for parametrizing GO materials using material and toxicity descriptors to contribute to nanomaterial safety.

pharmacology and toxicology↗

Nose-to-Brain Delivery of Cocaine in Mice: A Physiologically Based Pharmacokinetic Model Incorporating Olfactory Epithelial Transport, Mucociliary Clearance, and Blood-Brain Barrier Permeability

Intranasal (IN) cocaine produces rapid central nervous system (CNS) effects despite generating substantially lower plasma concentrations than equivalent intravenous (IV) doses, suggesting a direct nose-to-brain pathway. The olfactory epithelium provides anatomical continuity for cocaine to pass between the nasal cavity and the brain. Quantifying the relative contribution of this pathway to total brain cocaine exposure requires a physiologically-based pharmacokinetic (PBPK) model that explicitly accounts for nasal mucosal architecture, epithelial transport barriers, and blood-brain barrier (BBB) permeability. Here we used tandem mass spectrometry to collect cocaine concentration-time data from the brain and plasma of awake mice administered IV or IN cocaine and leveraged that data to generate such a framework. Our results provide evidence that following IN cocaine, the olfactory pathway accounts for approximately half of the cocaine that reaches the brain. The mechanistic PBPK framework developed here, incorporating anatomically grounded nasal compartment separation, blood-flow-scaled mucosal absorption, tissue diffusion resistance, mucociliary clearance, plasma protein binding, and BBB permeability-surface area transport, substantially improves upon empirical one-compartment absorption models and produces parameter estimates with physiological interpretability. The proportionate efficiency of the olfactory route relative to systemic absorption may provide a pharmacokinetic basis for the rapid onset of IN cocaines CNS effects and has direct implications for understanding the psychoactive effects of cocaine.

pharmacology and toxicology↗